UBS Maintains Neutral on FMC, Raises Price Target to $61
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has maintained a Neutral rating on FMC Corporation and increased the price target from $59 to $61.
January 11, 2024 | 3:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS has maintained a Neutral rating on FMC Corporation but raised the price target from $59 to $61, indicating a potential upside from the previous target.
The increase in price target by UBS suggests a positive outlook on FMC's valuation, which could lead to a short-term increase in investor confidence and potentially a rise in the stock price. However, since the rating remains Neutral, the impact may be moderate as it does not indicate a strong buy or sell signal.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100